Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 7, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • SADS-CoV, a new type of coronavirus can infect humans

Life Science Job With Rs. 35,000 pm Project Associate at THSTI

Is the frequent prescription of PPI medicines a boon or a bane?

SADS-CoV, a new type of coronavirus can infect humans
  • BiotechToday
  • World

SADS-CoV, a new type of coronavirus can infect humans

bioxone October 18, 2020October 18, 2020

 Devyani Goswami, Amity University Kolkata

SADS-CoV (Swine acute diarrhoea syndrome coronavirus), transmitted through the faeces of horseshoe bat to pigs. Majorly affecting the piglets, with death in 90% of the cases within 5 days. The major symptoms include diarrhoea and vomiting. SADS-CoV was identified first in 2004 and 2006 in the bats. First clinical signs in pigs were observed in China in late December 2016. 

Amid the tension of ongoing pandemic, this news struck a sudden thunder. The major fear being that, SADS-CoV and SARS-CoV has originated from the bat and can possibly have the same devastating effect on mankind. It was observed in the research that these virus are capable of using human liver, guts, and airway cells as hosts, similar to that of the piglets. Thus concluding of its ability to infect human as well. The scary part being the effect the virus would manifest in humans is yet unknown.

The major mode of transmission of this virus in humans would be through contact with the infected animals and further. Hence making the workers and animals at hog farms more vulnerable. 

It can heavily affect the pork industry of China, as China being the world’s larger swine producer. China issued immediate monitoring of the virus in the animals and are making efforts to have the situation under control. 

Also read: Are COVID-19 patients diagnosed with Down Syndrome prone to severe diseases?

REFERENCE: 1) A new Coronavirus fear? New strain seen in swine has potential to jump to humans, US study finds

https://www.scmp.com/news/asia/article/3105918/new-coronavirus-fear-new-strain-seen-swine-has-potential-jump-humans-us

2) Chinese Swine Acute Diarrhea Syndrome Coronavirus (SADS-CoV) Spurs SHIC Response

https://www.swinehealth.org/chinese-swine-acute-diarrhea-syndrome-coronavirus-sads-cov-spurs-shic-response/

3) Swine Acute Diarrhea Syndrome Coronavirus

https://en.m.wikipedia.org/wiki/Swine_acute_diarrhea_syndrome_coronavirus

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Related

Tagged China horseshoe bat new coronavirus piglets SADS-CoV SARS-CoV

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Is the frequent prescription of PPI medicines a boon or a bane?

bioxone October 18, 2020

Husna, Amity University Kolkata Proton pump inhibitors (PPIs) are a class of medicines that work on the cells which are lining the stomach, reducing the production of acid in our stomach. They can treat heartburn and gastric acid reflux by irreversibly binding with the Na+ H+ ATPase located on the surface of gastric parietal cells.PPIs […]

PPI

Related Post

  • BiotechToday
  • World

Fabrics with digital capabilities- World’s first “Fibre Computer”

BioTech Today July 1, 2021June 30, 2021

Subhajit Nan, Amity University, Kolkata. Researchers in the Massachusetts Institute of Technology (MIT) in the United States have recently made the world’s first fibre computer- a fibre with digital capabilities, which can sense, store, analyse and infer activity after being sewn into a shirt, thereby paving the path for the creation of the first-ever digital […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • India
  • World

Pfizer and Moderna: Long-Lasting Protection Against COVID-19

bioxone June 30, 2021July 5, 2021

Saptaparna Dasgupta, Bennett University A recently published new study states that both the Pfizer-BioNTech and Moderna COVID-19 vaccine immune system reactions have proved to offer long-lasting protection against COVID-19. mRNA vaccines have created more and better germinal centre B cell responses, thus indicating that the immunity system would be much more impactful and offer long-lasting […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • India

Big breakthrough! ICMR and BIOLOGICAL E LTD develop a potential treatment for Covid-19

bioxone October 2, 2020October 2, 2020

-Aishila Kar, Amity University Kolkata The Indian Council of Medical Research (ICMR) in partnership with Hyderabad-based vaccine maker Biological E, has developed a “highly purified antisera” which will be utilized in the prevention and treatment of Covid-19. Antisera are blood sera that carry antibodies against a selected viral toxin or antigen and are introduced to […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy